Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

12th Jul 2010 17:11

RNS Number : 2257P
GlaxoSmithKline PLC
12 July 2010
 



 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £11.33 per Ordinary share on 9 July 2010 through the Company's Share Reward Plan ("the Plan") which the under-mentioned persons entered on 5 October 2001:

 

Mr A P Witty

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr J S Heslop

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr S M Bicknell

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr E J Gray

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr S A Hussain

Acquisition of 6 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr D Learmouth

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Dr D Pulman

Acquisition of 12 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr D S Redfern

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Ms C Thomas

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr P J T Vallance

Acquisition of 11 Ordinary shares under the Dividend Reinvestment element of the Plan

 

 

The Company and the above-mentioned persons were advised of this information on 12 July 2010.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Deputy Company Secretary

12 July 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQLLFFBDFFBBB

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change0.00